Possible Treatment Finishes Trial

After announcing the inclusion of Raynaud’s phenomenon in its Phase 1 scleroderma cell therapy program in January, Cytori Therapeutics marked the completion of the 48-week follow-up clinical trial. Scleroderma is a condition that involves the skin and internal organs...

How Do Our Gloves Work?

Imagine a smart fabric that can generate heat just by touching your skin, can store this heat in an army of microscopically sized heating pads, and harvests and converts this energy into rays similar to what the sun emits below the visible spectrum of light. This is...